Metformin (METFORISE 1000 TABLET) is an oral antidiabetic agent, prescribed for type 2 diabetes. It helps control blood sugar levels. The information provided on this page is intended to serve as a ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET ® XR ...
Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...
MENLO PARK, Calif. -- Depomed announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the 1000 mg strength tablets of GlumetzaTM (metformin hydrochloride ...
Metformin 1000 mg sr price with mastercard online Glucophage SR may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin. A slow increase of dose may improve ...
Vildagliptin SR and Metformin SR tablets merge the potent mechanisms of vildagliptin and metformin to offer patients a comprehensive approach to managing their glycemic levels. Vildagliptin, a ...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE ™ XR (saxagliptin and metformin HCl extended-release), ...
Studies have shown that lack of adherence towards taking medicines as a major cause of diabetes related complications, hospitalization and deaths. DawaaDost, a retailer of affordable medicines has ...
https://www.thehindubusinessline.com/companies/laurus-labs-gets-usfda-approval-for-metformin-tablets/article24816752.ece Copy Laurus Labs has received approval for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results